Retina Partners of Northwest Arkansas, PLLC — Springdale, Arkansas

Retina Partners of Northwest Arkansas, PLLC is a clinical research site located in Springdale, Arkansas, United States 72764.

Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.

Retina Partners of Northwest Arkansas, PLLC has participated in 5 clinical trials with 4 currently active.

Therapeutic areas: Macular Degeneration, Age-Related Macular Degeneration, Choroidal Neovascularization.

Sponsors: EyeBiotech Ltd., Rophibio, Inc., Genentech, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Springdale

Browse all research sites in Arkansas · View every site in Springdale

Sponsor Feasibility Report

Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Retina Partners of Northwest Arkansas, PLLC?

Retina Partners of Northwest Arkansas, PLLC has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Retina Partners of Northwest Arkansas, PLLC conducted?

Retina Partners of Northwest Arkansas, PLLC has 5 clinical trials on record, with 4 currently active. Their work covers Macular Degeneration, Age-Related Macular Degeneration, Choroidal Neovascularization.

Is Retina Partners of Northwest Arkansas, PLLC accredited by Crixeo Clinical Trials?

Retina Partners of Northwest Arkansas, PLLC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Retina Partners of Northwest Arkansas, PLLC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.